European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) receptor ligands.
Tatsch
K
K
Asenbaum
S
S
Bartenstein
P
P
Catafau
A
A
Halldin
C
C
Pilowsky
L S
LS
Pupi
A
A
D001921:Brain / Q000000981:diagnostic imaging* / Q000378:metabolism; D001931:Brain Mapping / Q000379:methods; D005060:Europe; D006801:Humans; D007391:International Cooperation; D007457:Iodine Radioisotopes / Q000493:pharmacokinetics; D008024:Ligands; D009683:Nuclear Medicine / Q000379:methods / Q000592:standards; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D017448:Receptors, Dopamine D2 / Q000378:metabolism*; D012955:Societies, Medical; D009435:Synaptic Transmission / Q000502:physiology; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods / Q000592:standards*
D007457:Iodine Radioisotopes; D008024:Ligands; D019275:Radiopharmaceuticals; D017448:Receptors, Dopamine D2